Bayer wins newest Roundup most cancers trial, ending dropping streak

Bayer has received a trial in a lawsuit introduced by a California man who mentioned he developed most cancers from publicity to its Roundup weedkiller, ending what had been a five-trial dropping streak for the corporate in trials over related claims.

The decision was handed down on Friday by a jury in San Benito County, California Superior Court docket, Bayer introduced. The corporate mentioned in an announcement that the decision was “consistent with the evidence in this case that Roundup does not cause cancer and is not responsible for the plaintiff’s illness.”

Attorneys for plaintiff Bruce Jones didn’t instantly reply to requests for remark. Like most plaintiffs in Roundup lawsuits, Jones alleged that the product induced him to develop a type of most cancers known as non-Hodgkin lymphoma.

Round 165,000 claims have been made towards the corporate for private accidents allegedly attributable to Roundup, which Bayer acquired as a part of its $63 billion buy of U.S. agrochemical firm Monsanto in 2018.

Earlier than its recent string of losses, which produced verdicts towards the corporate totaling greater than $2 billion, Bayer had received 9 consecutive trials, that means it has now received 10 of the final 15 trials. Additional instances are anticipated to be tried within the coming 12 months.

Bayer is interesting the verdicts towards it, which embrace giant punitive damages awards which are more likely to be diminished as a result of they exceed U.S. Supreme Court docket steering.

The losses had led some traders to question Bayer’s legal strategy in defending the Roundup instances. The corporate said last month that it could proceed combating the instances in courtroom and had “no appetite to write humongous checks” to settle them.

In 2020, Bayer settled a lot of the then-pending Roundup instances for as much as $9.6 billion however did not get a settlement protecting future instances. Greater than 50,000 claims stay pending.